RLYB

Rallybio Corporation (RLYB)

About Rallybio Corporation (RLYB)

Rallybio Corp. engages in the identification, research and development, and manufacture of clinical biotechnology products and therapies for severe and rare diseases. Its product candidates focus on the areas of fetal and neonatal disorders, hematology, immuno-inflammation, and metabolic disease. The company was founded by Martin W. Mackay, Stephen Uden, and Jeffrey M. Fryer in January 2018 and is headquartered in New Haven, CT.

Details

Daily high

$0.73

Daily low

$0.62

Price at open

$0.68

52 Week High

$3.46

52 Week Low

$0.61

Market cap

26.5M

Dividend yield

0.00%

Volume

18,892

Avg. volume

44,992

P/E ratio

-.48

Rallybio Corporation News